{"id":168671,"date":"2024-03-10T03:13:14","date_gmt":"2024-03-10T07:13:14","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/alumis-presents-positive-data-from-phase-2-clinical-trial-of-esk-001-an-oral-allosteric-tyk2-inhibitor-for-the-treatment-of-plaque-psoriasis-at-aad\/"},"modified":"2024-08-18T11:47:45","modified_gmt":"2024-08-18T15:47:45","slug":"alumis-presents-positive-data-from-phase-2-clinical-trial-of-esk-001-an-oral-allosteric-tyk2-inhibitor-for-the-treatment-of-plaque-psoriasis-at-aad","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/alumis-presents-positive-data-from-phase-2-clinical-trial-of-esk-001-an-oral-allosteric-tyk2-inhibitor-for-the-treatment-of-plaque-psoriasis-at-aad.php","title":{"rendered":"Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD&#8230;"},"content":{"rendered":"<p><![CDATA[\u2013 STRIDE Phase 2 primary endpoint of PASI 75 and key secondary endpoints met at all clinically relevant doses tested; sustained maximal target inhibition safely achieved at top dose \u2013]]><\/p>\n<p>Read the rest here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/03\/09\/2843394\/0\/en\/Alumis-Presents-Positive-Data-from-Phase-2-Clinical-Trial-of-ESK-001-an-Oral-Allosteric-TYK2-Inhibitor-for-the-Treatment-of-Plaque-Psoriasis-at-AAD-Annual-Meeting.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD...\">Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the rest here: Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/alumis-presents-positive-data-from-phase-2-clinical-trial-of-esk-001-an-oral-allosteric-tyk2-inhibitor-for-the-treatment-of-plaque-psoriasis-at-aad.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-168671","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168671"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=168671"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168671\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=168671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=168671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=168671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}